Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Infectious Disease Reports
Published in: Current Infectious Disease Reports 2/2012

01-04-2012 | Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Topical Treatment of Chronic Suppurative Otitis Media

Author: Sam J. Daniel

Published in: Current Infectious Disease Reports | Issue 2/2012

Login to get access

Abstract

Chronic suppurative otitis media (CSOM) is a chronic inflammation of the middle ear and mastoid cavity presenting with ear discharge or otorrhea through a non-intact tympanic membrane. CSOM is the most common cause of childhood hearing impairment in developing countries. Accurate diagnosis depends on a high index of suspicion, micro-otoscopic examination, and judicious use of imaging as required. CSOM can be classified into 3 types: tubotympanic, atticoantral, and post-tympanostomy tube insertion. Aerobes, anaerobes and fungi are all potential pathogens in CSOM. This review summarizes the results of recent studies on the bacteriology of CSOM, biofilms, and the role of the nasopharynx pathogens that may have important implications for the treatment of this important pathology; that is often associated with misdiagnosis or delayed diagnosis. Particular emphasis will be placed on topical treatment options including choices of antibiotic, antifungal, and antiseptic agents, delivery technique, spectrum of activity, and risk of ototoxicity.
Literature
1.
Daniel SJ, Kozak FK, Fabian MC, et al. Guidelines for the treatment of tympanostomy tube otorrhea. J Otolaryngol. 2005;34 Suppl 2:S60–3.PubMed
2.
Roland PS. Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J. 2002;81(8 Suppl 1):8–10.PubMed
3.
Goycoolea MV, Hueb MM, Ruah C. Otitis media: the pathogenesis approach. Definitions and terminology. Otolaryngol Clin North Am. 1991;24(4):757–61.PubMed
4.
•• Madana J, Yolmo D, Kalaiarasi R, et al. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children. Int J Pediatr Otorhinolaryngol. 2011;75(9):1104–8. This study showed that in attico-antral CSOM with cholesteatoma, the most common organisms was P. aeruginosa, P. mirabilis and S. aureus; all were susceptibie to ceftazidime and vancomycin.PubMedCrossRef
5.
Bowd AD. Otitis media: health and social consequences for aboriginal youth in Canada’s north. Int J Circumpolar Health. 2005;64(1):5–15.PubMed
6.
Daly KA, Hunter LL, Giebink GS. Chronic otitis media with effusion. Pediatrics in review/American Academy of Pediatrics. 1999;20(3):85–93. quiz 94.PubMedCrossRef
7.
•• Mathew R, Asimacopoulos E, Valentine P. Toward safer practice in otology: A report on 15 years of clinical negligence claims. Laryngoscope. 2011;121(10):2214–9. This is the first study to report outcomes of negligence claims in otology. Claims in otology are associated with a high success rate. A significant proportion of claims are not related to surgery.PubMedCrossRef
8.
Kaplan GJ, Fleshman JK, Bender TR, et al. Long-term effects of otitis media: a ten-year cohort study of Alaskan Eskimo children. Pediatrics. 1973;52(4):577–85.PubMed
9.
Adoga AA, Bakari A, Afolabi OA, et al. Bacterial isolates in chronic suppurative otitis media: a changing pattern? Nigerian journal of medicine: journal of the National Association of Resident Doctors of Nigeria. 2011;20(1):96–8.
10.
Lee SK, Lee MS, Jung SY, et al. Antimicrobial resistance of Pseudomonas aeruginosa from otorrhea of chronic suppurative otitis media patients. Otolaryngol Head Neck Surg. 2010;143(4):500–5.PubMedCrossRef
11.
•• Brook I. The role of anaerobic bacteria in chronic suppurative otitis media in children: implications for medical therapy. Anaerobe. 2008;14(6):297–300. This article describes the microbiology, diagnosis and medical management of chronic suppurative otitis media (CSOM) in children highlighting the role of anaerobic bacteria.PubMedCrossRef
12.
Brook I. The role of anaerobic bacteria in otitis media: microbiology, pathogenesis, and implications on therapy. Am J Otolaryngol. 1987;8(2):109–17.PubMedCrossRef
13.
Brook I, Burke P. The management of acute, serous and chronic otitis media: the role of anaerobic bacteria. J Hosp Infect. 1992;22(Suppl A):75–87.PubMedCrossRef
14.
•• Brook I, Yocum P, Shah K. Aerobic and Anaerobic Bacteriology of Otorrhea Associated with Tympanostomy Tubes in Children. Acta Otolaryngol (Stockh). 1998;118:206–10. This article reveals that specimens collected from the external auditory canals can be misleading. Reliable information can be obtained from the ear exudates when collected through the tympanostomy tubes or through the open perforation after their removal.CrossRef
15.
•• Saunders J, Murray M, Alleman A. Biofilms in chronic suppurative otitis media and cholesteatoma: scanning electron microscopy findings. Am J Otolaryngol. 2011;32(1):32–7. Using scanning electron microscopy, this study showed that bacterial biofilms are common in chronic infections associated with cholesteatoma and are present in some cases of chronic suppurative otitis media without cholesteatoma.PubMedCrossRef
16.
• Chang J, Lee SH, Choi J, et al. Nasopharynx as a microbiologic reservoir in chronic suppurative otitis media: preliminary study. Clinical and experimental otorhinolaryngology. 2011;4(3):122–5. This study suggests that it is necessary to perform nasopharynx cultures together with conventional middle ear culture to orient antibiotherapy pre-operatively.PubMedCrossRef
17.
Browning GG, Gatehouse S, Calder IT. Medical management of active chronic otitis media: a controlled study. J Laryngol Otol. 1988;102(6):491–5.PubMedCrossRef
18.
Saunders MW, Robinson PJ. How easily do topical antibiotics pass through tympanostomy tubes?–an in vitro study. Int J Pediatr Otorhinolaryngol. 1999;50(1):45–50.PubMedCrossRef
19.
Boyd NH, Gottschall JA. Assessing the efficacy of tragal pumping: a randomized controlled trial. Otolaryngol Head Neck Surg. 2011;144(6):891–3. Epub 2011 Feb 18.PubMedCrossRef
20.
Hannley MT, Denneny 3rd JC, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000;122(6):934–40.PubMedCrossRef
21.
••Macfadyen CA, Acuin JM, Gamble C: Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Cochrane database of systematic reviews 2006(1):CD005608 (online 2009). This study shows that short courses of topical quinolone antibiotics are more effective than systemic antibiotics alone for the short-term resolution of otorrhea from uncomplicated CSOM.
22.
••Macfadyen CA, Acuin JM, Gamble C: Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations. Cochrane database of systematic reviews 2005(4):CD004618 (online 2009). In this review, short courses of topical quinolone antibiotics were shown to be more effective than no drug treatment or topical antiseptics for the short-term resolution of otorrhea from uncomplicated CSOM.
23.
Klein JO. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections. Am J Manag Care. 2002;8(14 Suppl):S345–52.PubMed
24.
Weber PC, Roland PS, Hannley M, et al. The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S89–94.PubMedCrossRef
25.
Agro AS, Garner ET, Wright 3rd JW, et al. Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media. Clin Ther. 1998;20(4):744–59.PubMedCrossRef
26.
Manolidis S, Friedman R, Hannley M, et al. Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S83–8.PubMedCrossRef
27.
Macfadyen C, Gamble C, Garner P, et al. Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Trop Med Int Health. 2005;10(2):190–7.PubMedCrossRef
28.
Leach AJ, Morris PS: Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane database of systematic reviews (Online) 2006(4):CD004401.
29.
Daniel SJ, Munguia R. Ototoxicity of topical ciprofloxacin/dexamethasone otic suspension in a chinchilla animal model. Otolaryngol Head Neck Surg. 2008;139(6):840–5.PubMedCrossRef
30.
Roland PS, Stewart MG, Hannley M, et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: Introduction, methodology, and recommendations. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S51–6.PubMedCrossRef
31.
Matz G, Rybak L, Roland PS, et al. Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S79–82.PubMedCrossRef
32.
Ichibangase T, Yamano T, Miyagi M, et al. Ototoxicity of Povidone-Iodine applied to the middle ear cavity of guinea pigs. Int J Pediatr Otorhinolaryngol. 2011;75(9):1078–81.PubMedCrossRef
33.
Boudewyns A, Claes J. Acute cochleovestibular toxicity due to topical application of potassium iodide. Eur Arch Otorhinolaryngol. 2001;258(3):109–11.PubMedCrossRef
34.
Oishi N, Inoue Y, Saito H, et al. Burow’s solution-induced acute sensorineural hearing loss: report of two cases. Auris Nasus Larynx. 2010;37(3):369–72.PubMedCrossRef
35.
Haynes DS, Rutka J, Hawke M, et al. Ototoxicity of ototopical drops–an update. Otolaryngol Clin North Am. 2007;40(3):669–83. xi. Review.PubMedCrossRef
36.
Daniel SJ, Akinpelu OV, Sahmkow S, et al. Oxymetazoline ototoxicity in a chinchilla animal model. Otolaryngol Head Neck Surg. 2012;146(1):114–8.PubMedCrossRef
37.
Isaacson G, Buttaro BA, Mazeffa V, et al. Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic. Ann Otol Rhinol Laryngol. 2005;114(8):645–51.PubMed
38.
•• Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72(4):453–9. This review discusses the topical antifungals most commonly used in otomycosis and their ototoxic potential. Candida albicans and Aspergillus are the most commonly identified organisms. Antifungals from the Azole class seem to be the most effective, followed by Nystatin and Tolnaftate.PubMedCrossRef
39.
• Daniel SJ, Sahmkow S, Akinpelu OV. Is Ototopical Nystatin Ototoxic?: A Chinchilla Model. Otolaryngol Head Neck Surg. 2011;145(6):1022–4. This study demonstrates the safety of topical nystatin in an animal model.PubMedCrossRef
Metadata
Title
Topical Treatment of Chronic Suppurative Otitis Media
Author
Sam J. Daniel
Publication date
01-04-2012
Publisher
Current Science Inc.
Published in
Current Infectious Disease Reports / Issue 2/2012
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-012-0246-8

Other articles of this Issue 2/2012

Current Infectious Disease Reports 2/2012 Go to the issue

Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Dacryocystitis: Systematic Approach to Diagnosis and Therapy

Sexually Transmitted Diseases (L Bachmann, Section Editor)

The Promise of Antiretrovirals for HIV Prevention

Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Effects of Active and Passive Smoking on Ear Infections

Invited Commentary

The Increased Risk of Community-Acquired Methicillin-Resistant Staphylococcus Aureus in Neck Infections in Young Children

Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Diagnosis and Management of Necrotizing Fasciitis of the Head and Neck

Sexually Transmitted Diseases (L Bachmann, Section Editor)

Herpes Diagnostic Tests and Their Use
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits